The role of environment and epigenetics in hypertension

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 11, 2013, Pages 1455-1457

  López Jaramillo, Patricio ^a,b   Camacho, Paul A ^a   Forero Naranjo, Leonardo ^a  

^a Research Institute of the Fundacion Oftalmologica de Santander FOSCAL   (Colombia)

^b UNIVERSIDAD DE SANTANDER   (Colombia)

Author keywords

adiponectin; environmental factors; epigenetic; hypertension; leptin

Indexed keywords

C REACTIVE PROTEIN; INSULIN;

ABDOMINAL OBESITY; ADIPOCYTE; AGING; ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENETIC PREDISPOSITION; GESTATIONAL AGE; HUMAN; HYPERTENSION; IN VITRO STUDY; INCOME; INDUSTRIALIZATION; INSULIN RESISTANCE; MALNUTRITION; METHYLATION; MORBIDITY; OBESITY; PREVALENCE; PROMOTER REGION; REVIEW; RISK FACTOR; SALT INTAKE; SOCIAL STRESS; SOUTH AND CENTRAL AMERICA; URBANIZATION; WATER RETENTION;

AGE FACTORS; AGING; ALCOHOL DRINKING; ENVIRONMENT; EPIGENESIS, GENETIC; HUMANS; HYPERTENSION; OBESITY; RISK FACTORS; SODIUM CHLORIDE, DIETARY; STRESS, PSYCHOLOGICAL;

EID: 84887381585     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2013.846217     Document Type: Review

References (20)

1. Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: Determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension 62(1), 18-26 (2013
2. WHO. A Global Brief on Hypertension. Silent Killer, Global Public Health Crisis. World Health Organization, Geneva, Switzerland (2013
3. Beaglehole R, Bonita R, Horton R et al. Priority actions for the non-communicable disease crisis. Lancet 377(9775), 1438-1447 (2011
4. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 371(9623), 1513-1518 (2008
5. Chow CK, Teo KK, Rangarajan S et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310(9), 959-968 (2013
6. Lopez-Jaramillo P, Lahera V, Lopez-Lopez J. Epidemic of cardiometabolic diseases: A Latin American point of view. Ther. Adv. Cardiovasc. Dis. 5(2), 119-131 (2011
7. Harrison M, Maresso K, Broeckel U. Genetic determinants of hypertension: An update. Curr. Hypertens. Rep. 10(6), 488-495 (2008
8. Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 377(9765), 529-532 (2011
9. Lopez-Jaramillo P, Silva SY, Rodriguez-Salamanca N et al. Are nutrition-induced epigenetic changes the link between socioeconomic pathology and cardiovascular diseases? Am. J. Ther. 15(4), 362-372 (2008
10. Ehret GB, Munroe PB, Rice KM et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478(7367), 103-109 (2011
11. Lopez-Jaramillo P. Cardiometabolic disease in Latin America: The role of fetal programming in response to maternal malnutrition. Rev. Esp. Cardiol. 62(6), 670-676 (2009
12. Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: Predicting biomarkers and therapeutic targets in human diseases. Clin. Genet. 74(4), 307-315 (2008
13. Fernandes MT, Sesso R, Martins PA et al. Increased blood pressure in adolescents of low socioeconomic status with short stature. Pediatr. Nephrol. 18(5), 435-439 (2003
14. Florencio TT, Ferreira HS, Cavalcante JC et al. Short stature, obesity and arterial hypertension in a very low income population in north-eastern Brazil. Nutr. Metab. Cardiovasc. Dis. 14(1), 26-33 (2004
15. Langley-Evans SC. Critical differences between two low protein diet protocols in the programming of hypertension in the rat. Int. J. Food Sci. Nutr. 51(1), 11-17 (2000
16. Bogdarina I, Welham S, King PJ et al. Epigenetic modification of the renin-Angiotensin system in the fetal programming of hypertension. Circ. Res. 100(4), 520-526 (2007
17. Franco MC, Casarini DE, Carneiro-Ramos MS et al. Circulating renin-Angiotensin system and catecholamines in childhood: Is there a role for birth weight? Clin. Sci. (Lond.) 114(5), 375-380 (2008
18. Bautista LE, Lopez-Jaramillo P, Vera LM et al Is C-reactive protein an independent risk factor for essential hypertension? J. Hypertens. 19(5), 857-861 (2001
19. López-Jaramillo P, Velandia-Carrillo C, Alvarez-Camacho J, Cohen DD, Śanchez-Solano T, Castillo-López G. Inflammation and hypertension: Are there regional differences? Int. J. Hypertens. 2013, 492094 (2013
20. Rueda-Clausen CF, Lahera V, Calderon J et al. The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors. Int. J. Cardiol. 139(1), 32-41 (2010